Overview

Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia

Status:
Recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to investigate the effects of exogenously administered nicotinamide riboside (NR) on brain energy metabolism, oxidative stress, and cognitive function in individuals with mild cognitive impairment (MCI) and mild Alzheimer's dementia (AD).
Phase:
Early Phase 1
Details
Lead Sponsor:
Mclean Hospital
Collaborator:
National Institute on Aging (NIA)
Treatments:
Niacin
Niacinamide
Nicotinic Acids